Director, Global Forecasting
Revolution Medicines
Summary
Reporting directly to the Sr. Director, Global Analytics and Insights, the Director, Global Forecasting role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. This role involves developing, refining, and communicating key strategic and revenue forecast assumptions and analyses to inform and support decision-making across the organization. This role will also work directly with Regional Forecasting leads to ensure consistency in forecast approach, assumptions, and analyses. The ideal candidate will have experience working on pipeline molecules in Oncology, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity. This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Job description
Responsibilities
- Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications.
- Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes.
- Communicates and aligns key internal stakeholders around key forecast assumptions.
- Understands complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics and uses this knowledge to develop strategic forecasts and plans.
- Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
- Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
- Participates in cross-functional teams to gather input for functional activities, and ensure alignment.
- Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast.
- Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
- Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts.
- Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
- Collaborates with vendor partners to manage various deliverables and analyses.
Required Skills, Experience and Education
- Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a related analytics/forecasting role.
- Experience developing long-range patient-based forecasts for oncology products.
- Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights.
- Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
- Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
- Demonstrated ability to influence senior management and key business partners.
- Proven experience in a smaller, rapidly growing, company.
- Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
- Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
- Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills
- 8+ years of experience in patient-based forecasting with focus in Oncology.
- Experience with targeted oncolytics.
- Experience working with Global teams.
- Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
Requirements
- Bachelor's degree required (MBA preferred)
- 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role
- 6+ years of experience in a related analytics/forecasting role
- Experience developing long-range patient-based forecasts for oncology products
- Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights
- Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
- Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
- Demonstrated ability to influence senior management and key business partners
- Proven experience in a smaller, rapidly growing, company
- Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
- Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication
- Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients
Benefits
- Competitive cash compensation
- Equity awards
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.